| Metric | Q4 2023 | Q3 2023 | Q4 2022 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $672M | — | — | — | — |
| Op. Income | $88M | — | — | — | — |
| Gross Margin | 44.5% | — | — | — | — |
| Net Margin | 12.3% | — | — | — | — |
| EPS (Diluted) | $0.72 | — | — | — | — |
| Free Cash Flow | -$150M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $672M |
| Cost of Revenue | $373M |
| GROSS PROFIT | $300M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $155M |
| SG&A Expenses | $155M |
| Other Expenses | $57M |
| Operating Expenses | $211M |
| Cost & Expenses | $584M |
| OPERATING INCOME | $88M |
| Interest Income | $519M |
| Interest Expense | $191M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $88M |
| Income Tax Expense | $11M |
| Net Income from Continuing Ops | $78M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $5M |
| NET INCOME | $83M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $83M |
| D&A | $29M |
| EBIT | $88M |
| EBITDA | $117M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $672M |
| Cost of Revenue | $373M |
| GROSS PROFIT | $300M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $155M |
| SG&A Expenses | $155M |
| Other Expenses | $57M |
| Operating Expenses | $211M |
| Cost & Expenses | $584M |
| OPERATING INCOME | $88M |
| Interest Income | $519M |
| Interest Expense | $191M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $88M |
| Income Tax Expense | $11M |
| Net Income from Continuing Ops | $78M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $5M |
| NET INCOME | $83M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $83M |
| D&A | $29M |
| EBIT | $88M |
| EBITDA | $117M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $83M |
| Depreciation & Amortization | $29M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $21M |
| Other Non-Cash Items | $21M |
| Change in Working Capital | -$262M |
| OPERATING CASH FLOW | -$108M |
| Capital Expenditure | -$41M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$42M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$31M |
| NET CASH FROM INVESTING | -$84M |
| Net Debt Issuance | -$245M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$154.6K |
| NET CASH FROM FINANCING | -$245M |
| FREE CASH FLOW | -$150M |
| Net Change in Cash | -$429M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.8B |
| Short-Term Investments | $6.3B |
| Net Receivables | $1.5B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $10.7B |
| PP&E (Net) | $233M |
| Goodwill | $194M |
| Intangible Assets | $295M |
| Long-Term Investments | $13.9B |
| Tax Assets | $16M |
| Other Non-Current Assets | $675M |
| TOTAL NON-CURRENT ASSETS | $15.3B |
| TOTAL ASSETS | $26.0B |
| Account Payables | $69M |
| Short-Term Debt | $583M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $14.0B |
| TOTAL CURRENT LIABILITIES | $14.7B |
| Long-Term Debt | $2.5B |
| Deferred Revenue NC | $299M |
| Deferred Tax Liabilities | $22M |
| Other Non-Current Liabilities | $5.5B |
| TOTAL NON-CURRENT LIABILITIES | $8.4B |
| TOTAL LIABILITIES | $23.1B |
| Common Stock | $301M |
| Additional Paid-In Capital | $154M |
| Retained Earnings | $846M |
| Treasury Stock | -$24M |
| Accum. Other Comp. Income | $1.6B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.9B |
| Minority Interest | $17M |
| TOTAL EQUITY | $2.9B |
| TOTAL LIABILITIES & EQUITY | $26.0B |
| Total Debt | $3.1B |
| Net Debt | $370M |
